Page last updated: 2024-08-25

terlipressin and Liver Dysfunction

terlipressin has been researched along with Liver Dysfunction in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Anand, A; Deep, A; Saxena, R1
Golestaneh, L; Neugarten, J1
Gow, P; Papaluca, T1
Lee, HJ; Oh, MJ1
Abdelaal, A; Aboulfetouh, F; Bahaa, M; El-Meteini, M; Fathy, M; Hassanien, A; Mostafa, I; Mukhtar, A; Obayah, G; Rady, M; Saeed, H; Salah, M; Samy, M1
Herlenius, G; Oltean, M1
Chan, AC; Chan, SC; Cheung, TT; Chok, KS; Fan, ST; Fung, JY; Lo, CM; Sharr, WW1
Choi, JH; Chun, HJ; Hyun, JJ; Jeen, YT; Keum, BR; Kim, CD; Kim, YH; Kim, YS; Lee, HS; Lee, SW; Park, S; Ryu, HS; Seo, YS; Um, SH1

Reviews

2 review(s) available for terlipressin and Liver Dysfunction

ArticleYear
Dual Organ Duel: The Hepatorenal Axis.
    Advances in chronic kidney disease, 2017, Volume: 24, Issue:4

    Topics: Acute Kidney Injury; Animals; Antihypertensive Agents; Antiviral Agents; Cytochrome P-450 Enzyme System; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Diseases; Lypressin; Renal Insufficiency, Chronic; Terlipressin

2017
Terlipressin: Current and emerging indications in chronic liver disease.
    Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:3

    Topics: Chronic Disease; Humans; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Liver Diseases; Lypressin; Portal Pressure; Renal Circulation; Terlipressin

2018

Trials

2 trial(s) available for terlipressin and Liver Dysfunction

ArticleYear
The use of terlipressin during living donor liver transplantation: Effects on systemic and splanchnic hemodynamics and renal function.
    Critical care medicine, 2011, Volume: 39, Issue:6

    Topics: Adult; Blood Pressure; Female; Humans; Intraoperative Care; Kidney; Kidney Function Tests; Liver Diseases; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Terlipressin; Vascular Resistance; Vasoconstrictor Agents

2011
[A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis].
    The Korean journal of hepatology, 2006, Volume: 12, Issue:3

    Topics: Acute Disease; Aged; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hemostasis, Endoscopic; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Lypressin; Male; Middle Aged; Multivariate Analysis; Somatostatin; Terlipressin; Varicose Veins; Vasoconstrictor Agents

2006

Other Studies

4 other study(ies) available for terlipressin and Liver Dysfunction

ArticleYear
Use of terlipressin in critically ill children with liver disease.
    BMC nephrology, 2020, 08-20, Volume: 21, Issue:1

    Topics: Acute Kidney Injury; Adolescent; Ascites; Child; Creatinine; Critical Illness; Cyanosis; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Intensive Care Units, Pediatric; Ischemia; Liver Diseases; Male; Terlipressin; Vasoconstrictor Agents

2020
A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease.
    Clinical and molecular hepatology, 2013, Volume: 19, Issue:2

    Topics: Aged; Creatinine; Foot; Gangrene; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Lypressin; Male; Osteomyelitis; Radiography; Severity of Illness Index; Terlipressin; Toe Phalanges; Vasoconstrictor Agents

2013
Renal protection during liver transplantation: an ounce of prevention is worth a pound of cure.
    Critical care medicine, 2011, Volume: 39, Issue:6

    Topics: Humans; Kidney Diseases; Liver Diseases; Liver Transplantation; Lypressin; Terlipressin; Vasoconstrictor Agents

2011
Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2012, Volume: 18, Issue:7

    Topics: Adult; Albumins; Comorbidity; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Dialysis; Risk Factors; Terlipressin; Treatment Outcome

2012